Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices
复制标题
DOI:
10.1016/j.jaci.2019.03.022
复制
发表时间:
2019-07-01
影响因子:
14.2
通讯作者:
Notarangelo, Luigi D.
中科院分区:
文献类型:
--
作者:
Daley, Stephen R.;Koay, Hui-Fern;Notarangelo, Luigi D.
Stephen R. Daley, PhDa, Hui-Fern Koay, PhDb, c, Kerry Dobbs, MScd, Marita Bosticardo, PhDd, Rushika C. Wirasinha, PhDa, Francesca Pala, PhDd, Riccardo Castagnoli, MDd, Jared H. Rowe, MD, PhDe, Lisa M. Ott de Bruin, MD, PhDf, Sevgi Keles, MDg, Yu Nee Lee, PhDh, Raz Somech, MD, PhDh, Steven M. Holland, MDd, Ottavia M. Delmonte, MDd, Debbie Draper, RN, BSNd, Sandra Maxwell, RN, BSNd, Julie Niemela, MSi, Jennifer Stoddard, BSi, Sergio D. Rosenzweig, MD, PhDi, Pietro Luigi Poliani, MD, PhDj, Valentina Capo, PhDk, Anna Villa, MDk, l, Dale I. Godfrey, PhDb, c, Luigi D. Notarangelo, MDd aInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia; bDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia; cAustralian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Australia; dLaboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md; eDivision of Hematology-Oncology, Boston Children’s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Mass; fDivision of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, Mass; gDivision of Pediatric Immunology and Allergy, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey; hImmunology Service, Edmond and Lily Safra Children’s Hospital Sheba Medical Center, Tel Hashomer, Israel; iImmunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md; jDepartment of Molecular and Translational Medicine, Pathology Unit, University of Brescia, Brescia, Italy; kSan Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy; stephen. daley@ monash. edu. Disclosure of potential conflict of interest: LD Notarangelo is supported by the National Institute of Allergy and Infectious Diseases; has board memberships with the Journal of Clinical Immunology, Clinical Immunology, and Frontiers in Immunology; and has received royalties from UpToDate. The rest of the authors declare that they have no relevant conflicts of interest.